A Single Institution Experience with a Shear-Thinning Conformable Embolic for Endovascular Embolization

Area of Science:

• Interventional Radiology
• Vascular Surgery
• Medical Devices

Background:

• Embolization is a critical procedure for managing various vascular conditions.
• The development of advanced embolic agents is crucial for improving procedural outcomes and patient safety.
• Obsidio™ conformable embolic (CE) is a novel agent designed for peripheral vascular embolization.

Purpose of the Study:

• To evaluate the safety and efficacy of Obsidio™ conformable embolic (CE) in peripheral vasculature embolization.
• To assess the technical and clinical success rates of CE in a patient cohort.
• To identify any adverse events or complications associated with CE use.

Main Methods:

• Retrospective review of the first 21 patients treated with CE.
• Technical success defined as complete stasis on post-embolization angiography.
• Clinical success defined as hemorrhage resolution without reintervention within 30 days for hemorrhage cases.

Main Results:

• 100% technical success rate (21/21 patients) achieving complete stasis.
• Indications included peripheral arterial hemorrhage, tumor embolization, and variceal embolization.
• No post-procedure adverse events or rebleeding were reported.

Conclusions:

• Obsidio™ conformable embolic (CE) provides reliable vessel occlusion.
• CE demonstrated a favorable safety profile with no procedure-related adverse events.
• The study supports CE as an effective option for peripheral embolization procedures.